This is default featured slide 1 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 2 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 3 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 4 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured slide 5 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

Sunday, May 27, 2012

How to Beat Jetlag and Sleep Better on the Go

AppId is over the quota
AppId is over the quota

By Janene Mascarella

airplane-sky.jpg

What is it about traveling that often has us tossing and turning under those crisp, white hotel sheets? Even in the most luxurious accommodations, it can be hard to get a restorative, restful night's sleep. To help you rise and shine on the road, we asked Ph.D nutritionist and author of How to Stay Healthy and Fit on the Road, Joanne Lichten, (known as Dr. Jo) to shed some light and share her secrets on how to catch some zzz's.

Dr. Jo: Just got back from Ireland where we succeeded in having no jet lag in either direction—and there's a science to it. It takes roughly one day for your body to adjust naturally to each hour of time change. So, if you're traveling across 5 time zones and staying 7 days, by the time your body adjusts it will almost be time to leave! To hasten the recovery:

1. Consider the zeitgebers. These are external cues that reset the body clock. The strongest zeitgebers are light and dark. A dark environment will help your body naturally produce melatonin which makes you feel sleepy. And daylight will help you feel alert (get at least 30 minutes of daylight upon arriving in the daytime hours). So, get out in the light before heading inside. And, please don't go right to sleep!

2. Pre-set your watch. Upon leaving your hometown set your watch to the new time zone and start living accordingly. For example, when boarding on an eastbound flight at 8pm local time (1am in your new location), put on an eye mask and neck pillow and try to get some sleep.

3. Use naps judiciously. If trying to adapt to the new time zone is proving to be dangerous, feel free to take a daytime nap of about 90 minutes (as long as it's before 3pm local time). A short nap may prove to be difficult because when you're sleep deprived (such as sleeping just a few hours on an overseas flight), you're much more likely to fall into a deep sleep stage immediately and trying to wake up in 15 minutes will make you feel lethargic.  Consider that our sleep cycles (light sleep to deep sleep and back to light sleep) takes about 90-100 minutes.

Dr. Jo: Yes! Go for the carbs! It's important to eat protein at breakfast and lunch because meals rich in protein help the body to produce dopamine which can help you feel alert. Meals rich in carbs increase the release of serotonin which make you feel relaxed. In addition, you should never go to bed on a full stomach–that will disturb your sleep. Alcohol, while it might make you feel sleepy can interfere with your sleep, while both caffeine and nicotine are stimulating.

Dr. Jo: Give yourself a stopping point. Caffeine has a half-life of four hours. That means if you drink a very large cup of coffee with 400mg, 200mg will still be floating around in your bloodstream four hours later. And, 100mg 8 hours after you drank it. Most people sleep better by limiting their caffeine after the lunch hour.

Dr. Jo: Make it dark. When it gets dark, the pineal gland at the base of our brain secretes melatonin which helps us feel sleepy. Help the process by establishing a night-time routine including dimming the lights, turning off stimuli like computers and TV, using an eye mask, covering the bright light of the alarm clock, laying a towel in front of the door, and clipping the drapes shut (inside tip: pack a few binder clips!).

Photo credits: Hotel Room via Shutterstock; Airplane via Shutterstock


View the original article here

New Ivy Hotel Adds to Chicago's Boutique Scene

AppId is over the quota
AppId is over the quota

By Kristine Hansen

IVY-HOTEL041.jpg

Chicago's boutique-hotel boom continues on the heels of PUBLIC Chicago, Radisson Blu Aqua Hotel, and Hotel Lincoln with The Ivy Hotel, which just opened this month. (Rates from $225/night.)

Tucked into Chicago's tony Near North neighborhood, The Ivy Hotel caters to the urban eco-chic crowd who yearn to be close to designer shops on Michigan Avenue (the hotel is a block east) but that also have a passion for practicing environmental conservation. Guests are shuttled around, at no cost, in the hotel's two Lexus hybrid cars (will be available after the fall) and paperless check-in is done on iPads. Inside the shell of a vacant building for close to a decade, and most recently an office building, the revamped décor is largely neutral tones and guests enter the lobby under a soft, orange-red, white, or blue (depending on the time of day) glow.

A rooftop lounge on the 16th floor serving cocktails and tapas will properly usher in summer weather at the sleek hotel. And in the lobby lounge a four-course lunch or dinner can be arranged, folding in organic produce from two local purveyors.

On each floor, guests will find just four or five rooms (for a total of 63), which helps cultivate a quiet haven after a day of sightseeing. In fact, each suite has a soaking tub complete with lavender sea salts to coax away stress. Also in the rooms are 19-inch LED television built into the bathroom mirrors; bamboo flooring; rugs spun from spisal; linens (bed sheets, towels, and robes) created from Fair Trade, organic cotton; and amenity bottles featuring post-consumer recycled content. Non-toxic cleaning products, eco-friendly water and energy conservation, and recycling programs are also in place.

For up-to-the-minute hotel and restaurant recommendations, as well as the best planning advice, check out our Chicago Travel Guide.

Photo credits: Courtesy of the Ivy Hotel


View the original article here

Top Chef Comes to New York, Win a Ticket to Judge for Yourself

AppId is over the quota
AppId is over the quota
TopChefTour.1.jpg

Have you ever had the feeling that Tom or Padma got it wrong? Ever feel like you'd make a better Top Chef judge? Well here's your chance to say it to their faces. On May 20, Top Chef: The Tour is making its way to New York City to the Gansevoort Plaza (at the intersection of Gansevoort St. and 9th Avenue) in the Meatpacking District, giving us the chance to get up close and personal with the show we all hold so dear. The best part is, Fodor's is going to be there loud and proud with a booth where we'll be giving away an Escape with Fodor's' prize pack, valued at over $300!

Come 3 pm, it will be time to gather round the Top Chef tent and cooking demo area for, what else, a Quickfire-style cook-off. And while not everyone gets to judge the food served by dueling alums Antonia Lofaso and Hung Huynh, I do. That's right, yours truly will be on hand to tell Antonia if her dish fell flat or if Hung overdid it with the salt. (Note: there are three other cook-offs throughout the day with other chefs and judges.)

So come by and say hello! It's free to walk around and check out the booths (there's a putting green, interactive booth, and, of course, the Fodor's tent) and meet the chefs, but you'll need tickets to see the cook-offs and demos. Don't worry if you haven't gotten yours yet, though, because we're giving some away!

Enter to win 2 tickets to the Top Chef VIP reserved cooking demo courtesy of Fodor's. Note: You must be in NYC on May 20th to be eligible. By entering the sweepstakes, you will be subscribed to the Fodor's newsletter. You may unsubscribe at anytime.

Photo credits: Courtesy of Bravo TV; Chef chopping via Shutterstock


View the original article here

The Obama Cocktail Comes to Boston

AppId is over the quota
AppId is over the quota

By Kristine Hansen

1BHHB-Wine-Dine.jpg

On the heels of President Barack Obama's statement last week in support of marriage equality, a Boston hotel rolled out a cocktail a few days later that's in honor of this celebratory moment for the gay community.

"The Obama," the Beacon Hill Hotel & Bistro signature libation, contains Lillet Blanc, gin, fresh blueberries, and tonic water (L for Lillet, G for gin, B for blueberries, T for tonic.). It will be served on the rocks, garnished with two blueberries, in the hotel's bar daily through June 10, which is when Boston's annual Gay Pride Week ends. Each drink costs $11.

The drink is appropriately timed with an influx of gay-friendly travelers arriving to Boston for Pride Week (including the 2012 parade, which is a march to promote equal rights for gay, lesbian, and transgender people nationwide). Yet it also pays tribute to 30 years of the Pride movement worldwide, and the International Association of Pride Organizers (founded in Boston in 1982).

With just 13 rooms, Beacon Hill Hotel & Bistro–in Boston's historic and chic Beacon Hill neighborhood near the Public Garden—fuses modern amenities (the cocktail's innovative mixology, just one example) with a quaint charm. Breakfast, lunch, and dinner, as well as weekend brunch, is served daily.

For up-to-the-minute hotel and restaurant recommendations, plus the best planning advice, check out our Boston Travel Guide.

Photo credits: Courtesy of the Beacon Hill Hotel & Bistro


View the original article here

Evolutionary Medicine Conference Tue May 8 at Stanford

AppId is over the quota AppId is over the quota

New Opportunities at the Intersection of Evolution and Medicine
A gathering of scientists and entrepreneurs


8:00 – 8:30 Coffee and Registration


8:30 – 8:50 Welcome
Charles Cho, MD, Associate Professor Neurology and Neurological Sciences, Stanford University

Introductory Remarks by Joon Yun, MD, Palo Alto Investors and David Sloan Wilson, Binghamton University


8:50 – 9:30 Keynote Address
Evolutionary Medicine: Envisioning the Opportunities
Keynote Address by Randolph M. Nesse, MD, University of Michigan


9:30 – 10:10 Session One: Infectious Disease
Evolution Proof Pharmaceuticals?
Andrew F. Read, Penn State


Panel discussion to follow moderated by David Sloan Wilson, Binghamton University
Panelists include James Holland Jones, Stanford University, and Nina Kjellson, Interwest


10:10 – 10:40 Break


10:40 – 11:45 Session Two: Cancer
Why Evolution Holds the Key to Curing and Preventing Cancer
Carlo C Maley, University of California at San Francisco


The Evolution and Ecology of Metastasis: Can we Control Cancer by Targeting Dispersal Evolution?
Athena Aktipis, Arizona State University, UCSF Center for Evolution and Cancer


Panel discussion to follow moderated by Randolph M. Nesse
Panelists include Daniel S. Fisher, Stanford University


11:45 – 12:30 Session Three: Application of a Specific Theory
Using Drugs to Induce Adaptation
Introduced and moderated by Joon Yun, MD, Palo Alto Investors


Panelists include Ray Onders, Synapse; Lorenzo DiCarlo, Proteus Biomedical; Richard A. Bond, University of Houston; Kari Nadeau, Stanford University


12:30 – 1:30 Lunch


1:30 – 2:15 Session Four: Behavior
Improving Health by Changing Behavior: Evolution Science Shows How
Steven C. Hayes, University of Nevada


Panel discussion to follow moderated by David Sloan Wilson
Panelists include William H. Durham, Stanford University, and Camille Samuels, Versant Ventures


2:15 – 3:00 Session Five: Genetics and Mental Disorders
Where Darwin meets Freud: Psychiatric Conditions and Therapies at the Dawn of Evolutionary Genomics.
Bernie Crespi, Simon Fraser University


Panel discussion to follow moderated by Randolph M. Nesse
Panelists include Charles Cho, MD, Associate Professor Neurology and Neurological Sciences, Stanford University


3:00 – 3:30 Break


3:30 – 4:15 Session Six: Diet
What did Humans Evolve to Eat? Evolutionary Perspectives on Human Nutritional Health
William R. Leonard, Northwestern University


Panel discussion to follow moderated by David Sloan Wilson
Panelists include Dr. John Morton, Stanford University, and Scott Wolf, Aerin Medical


4:15 – 5:00 Session Seven: Aging
Can we Have it All? What Evolutionary Biology Says about Medically Slowing Aging.
Steven Austad, University of Texas Health Science Center San Antonio


Panel discussion to follow moderated by Joon Yun, MD, Palo Alto Investors
Panelists include Jim Glasheen, Technology Partner


5:00 – 5:15 Wrap


5:30 – 6:30 Cocktails & Networking


Full information available here


 

Evolutionary Medicine Conference Tue May 8 at Stanford

AppId is over the quota AppId is over the quota

New Opportunities at the Intersection of Evolution and Medicine
A gathering of scientists and entrepreneurs


8:00 – 8:30 Coffee and Registration


8:30 – 8:50 Welcome
Charles Cho, MD, Associate Professor Neurology and Neurological Sciences, Stanford University

Introductory Remarks by Joon Yun, MD, Palo Alto Investors and David Sloan Wilson, Binghamton University


8:50 – 9:30 Keynote Address
Evolutionary Medicine: Envisioning the Opportunities
Keynote Address by Randolph M. Nesse, MD, University of Michigan


9:30 – 10:10 Session One: Infectious Disease
Evolution Proof Pharmaceuticals?
Andrew F. Read, Penn State


Panel discussion to follow moderated by David Sloan Wilson, Binghamton University
Panelists include James Holland Jones, Stanford University, and Nina Kjellson, Interwest


10:10 – 10:40 Break


10:40 – 11:45 Session Two: Cancer
Why Evolution Holds the Key to Curing and Preventing Cancer
Carlo C Maley, University of California at San Francisco


The Evolution and Ecology of Metastasis: Can we Control Cancer by Targeting Dispersal Evolution?
Athena Aktipis, Arizona State University, UCSF Center for Evolution and Cancer


Panel discussion to follow moderated by Randolph M. Nesse
Panelists include Daniel S. Fisher, Stanford University


11:45 – 12:30 Session Three: Application of a Specific Theory
Using Drugs to Induce Adaptation
Introduced and moderated by Joon Yun, MD, Palo Alto Investors


Panelists include Ray Onders, Synapse; Lorenzo DiCarlo, Proteus Biomedical; Richard A. Bond, University of Houston; Kari Nadeau, Stanford University


12:30 – 1:30 Lunch


1:30 – 2:15 Session Four: Behavior
Improving Health by Changing Behavior: Evolution Science Shows How
Steven C. Hayes, University of Nevada


Panel discussion to follow moderated by David Sloan Wilson
Panelists include William H. Durham, Stanford University, and Camille Samuels, Versant Ventures


2:15 – 3:00 Session Five: Genetics and Mental Disorders
Where Darwin meets Freud: Psychiatric Conditions and Therapies at the Dawn of Evolutionary Genomics.
Bernie Crespi, Simon Fraser University


Panel discussion to follow moderated by Randolph M. Nesse
Panelists include Charles Cho, MD, Associate Professor Neurology and Neurological Sciences, Stanford University


3:00 – 3:30 Break


3:30 – 4:15 Session Six: Diet
What did Humans Evolve to Eat? Evolutionary Perspectives on Human Nutritional Health
William R. Leonard, Northwestern University


Panel discussion to follow moderated by David Sloan Wilson
Panelists include Dr. John Morton, Stanford University, and Scott Wolf, Aerin Medical


4:15 – 5:00 Session Seven: Aging
Can we Have it All? What Evolutionary Biology Says about Medically Slowing Aging.
Steven Austad, University of Texas Health Science Center San Antonio


Panel discussion to follow moderated by Joon Yun, MD, Palo Alto Investors
Panelists include Jim Glasheen, Technology Partner


5:00 – 5:15 Wrap


5:30 – 6:30 Cocktails & Networking


Full information available here


 

Evolutionary Medicine Conference Tue May 8 at Stanford

AppId is over the quota AppId is over the quota

New Opportunities at the Intersection of Evolution and Medicine
A gathering of scientists and entrepreneurs


8:00 – 8:30 Coffee and Registration


8:30 – 8:50 Welcome
Charles Cho, MD, Associate Professor Neurology and Neurological Sciences, Stanford University

Introductory Remarks by Joon Yun, MD, Palo Alto Investors and David Sloan Wilson, Binghamton University


8:50 – 9:30 Keynote Address
Evolutionary Medicine: Envisioning the Opportunities
Keynote Address by Randolph M. Nesse, MD, University of Michigan


9:30 – 10:10 Session One: Infectious Disease
Evolution Proof Pharmaceuticals?
Andrew F. Read, Penn State


Panel discussion to follow moderated by David Sloan Wilson, Binghamton University
Panelists include James Holland Jones, Stanford University, and Nina Kjellson, Interwest


10:10 – 10:40 Break


10:40 – 11:45 Session Two: Cancer
Why Evolution Holds the Key to Curing and Preventing Cancer
Carlo C Maley, University of California at San Francisco


The Evolution and Ecology of Metastasis: Can we Control Cancer by Targeting Dispersal Evolution?
Athena Aktipis, Arizona State University, UCSF Center for Evolution and Cancer


Panel discussion to follow moderated by Randolph M. Nesse
Panelists include Daniel S. Fisher, Stanford University


11:45 – 12:30 Session Three: Application of a Specific Theory
Using Drugs to Induce Adaptation
Introduced and moderated by Joon Yun, MD, Palo Alto Investors


Panelists include Ray Onders, Synapse; Lorenzo DiCarlo, Proteus Biomedical; Richard A. Bond, University of Houston; Kari Nadeau, Stanford University


12:30 – 1:30 Lunch


1:30 – 2:15 Session Four: Behavior
Improving Health by Changing Behavior: Evolution Science Shows How
Steven C. Hayes, University of Nevada


Panel discussion to follow moderated by David Sloan Wilson
Panelists include William H. Durham, Stanford University, and Camille Samuels, Versant Ventures


2:15 – 3:00 Session Five: Genetics and Mental Disorders
Where Darwin meets Freud: Psychiatric Conditions and Therapies at the Dawn of Evolutionary Genomics.
Bernie Crespi, Simon Fraser University


Panel discussion to follow moderated by Randolph M. Nesse
Panelists include Charles Cho, MD, Associate Professor Neurology and Neurological Sciences, Stanford University


3:00 – 3:30 Break


3:30 – 4:15 Session Six: Diet
What did Humans Evolve to Eat? Evolutionary Perspectives on Human Nutritional Health
William R. Leonard, Northwestern University


Panel discussion to follow moderated by David Sloan Wilson
Panelists include Dr. John Morton, Stanford University, and Scott Wolf, Aerin Medical


4:15 – 5:00 Session Seven: Aging
Can we Have it All? What Evolutionary Biology Says about Medically Slowing Aging.
Steven Austad, University of Texas Health Science Center San Antonio


Panel discussion to follow moderated by Joon Yun, MD, Palo Alto Investors
Panelists include Jim Glasheen, Technology Partner


5:00 – 5:15 Wrap


5:30 – 6:30 Cocktails & Networking


Full information available here


 

Virgin Atlantic Offers Mobile Service in the Skies

AppId is over the quota
AppId is over the quota

By Deanna Cioppa

Virgin-Atlantic-Plane.jpg

What goes through your head when the flight attendants announce that it's time to turn off phones and electronic devices? Is it "ah, finally, peace and quiet," "wait! I forgot to call [someone not that important]," or do you smile snidely and take no heed of their direction? Well, you're not going to hear that announcement for much longer, on Virgin Atlantic flights anyway.

With the official reveal of its Airbus 330-300 (flying between New York and London), the airline is offering in-flight cell phone usage for its flyers. According to a release, passengers on the new Airbus will be able to make calls, send and receive texts and emails, and have access to the web at 35,000 feet, via General Packet Radio Service (GPRS). By the end of the year, the airline says the service will be available for nearly 20 of its aircraft. The cost of the service is a bit steep—one British pound (or about $1.59) per minute, but can go up based on your network provider.

While the service is available throughout the plane, Virgin says it's mainly directed at business travelers who need to make a short call or send an email or two—"exceptional situations," as the airline puts it. To that end, only six users will be able to connect to the service at a time.

Despite that low number, some have been voicing concern over the potential for loud (or worse, boring) phone chit-chat in cabins. After Tuesday's announcement, the Associated Press wrote, "The British airline's new service could be a blessing for business travelers who want to stay connected during eight-hour flights across the ocean. It could also be a nightmare for the passenger sitting next to them."

Sarah McIntyre at Virgin's U.S. public relations office tried to assuage those worries. "This is more about people making a brief call to the car picking them up," she said in a phone interview, and not meant for passengers to be "chatting away." The feedback during the airline's trial period with the new service, she said, has been "very positive so far."

This development and the new Airbus is part a $160 million investment by Virgin Atlantic. Other digital goodies include a "technology hub" in the new airplane's Upper Class cabin with connections for smartphones, USB, and tablets, and a new in-flight entertainment system called Jam.

The service, dubbed AeroMobile, is initially available for customers using the O2 and Vodafone mobile networks. Service will still be unavailable during takeoff, landing, and within 250 miles of US airspace.

What do you think of Virgin Atlantic's new phone service? Weigh in in the comments below.

Photo credits: Courtesy of Virgin Atlantic


View the original article here

Levels of Selection, Logical Schemes, Selfish Genes, and Misleading Memes

AppId is over the quota
AppId is over the quota

Both Nature and Science are currently celebrating the 100th anniversary of the birth of an icon of logic, computer science, and mathematical biology: Alan Turing.  In reading Andrew Hodges’s spectacular biography of Turing (1983) many years ago I came to appreciate that the subject of the book was both a deeply creative and extraordinarily rigorous thinker.  Although Turing is known for seminal achievements in mathematical logic and computer science, his most directly practical and immediately consequential contribution was his facilitation of the Allied cause in World War II through his guidance of the effort to break the Nazi military code.  This effort called primarily on his prodigious talents for far-reaching inference and it was in reading about this effort that I was prompted to consider a concept that might be called “maximum deduction.”  Turing and his able colleagues needed to make every possible deductive inference (or at least very close to every possible inference) supported by the available data on German military communications in order to solve a problem of immense and immediate impact (the saving of Allied ships from devastating German submarine attacks).

In reading Samir Okasha’s thorough and insightful guide to the theoretical debates about multi-level selection, Evolution and the Levels of Selection (2006), I am reminded of Turing’s logical rigor. Like Turing, Okasha possesses the ability to fully explore the implications of an intellectual position.  Of similar value, he makes key distinctions that elude or at least receive inadequate attention from others and fairly assesses alternative conceptual schemes or theoretical approaches.  For example, his examination of the relative merits of the Price equation versus what he refers to as the “contextual analysis” for assessing and partitioning selection in differing evolutionary scenarios reveals that each has important advantages as well as significant weaknesses.  Much to his credit, he does not seek a neat but oversimplified and misleading conclusion.  The figures are simple but effective and substantially aid the exposition.

I cannot attempt to summarize all of the arguments in the book of about 240 pages because Okasha’s arguments are of sufficient intricacy and subtlety that it would be nearly impossible to substantially compress them without causing serious distortions in the reasoning.  Therefore, I will just note the topics addressed and remark on a limited number of particularly interesting points.

Okasha begins the book by introducing and characterizing the levels-of-selection problem and explicating the essence of natural selection in abstract formal terms.  He then addresses the distinction between the synchronic and diachronic perspectives, where the former deals with the hierarchical organization of the living world (e.g. cells, multicellular organisms, communities of multicellular organisms) such as it is and the latter is concerned with how the hierarchy arose.  Next, the author introduces and explains the interpretation of the equation formulated by George Price forty years ago to describe in mathematical terms the evolution of a population from one generation to the next.  He also delves into the sometimes-consequential differences between statistical and causal decompositions of changes in organismal characters across generation.  This chapter ends with an interesting discussion of the connections between the Price equation and the formal conditions for evolution promulgated more than forty years ago by the eminent population geneticist, Richard Lewontin, which were initially described at the beginning of the chapter.

The second chapter explains the fundamentals of multi-level selection, including explorations of life cycles, relevant definitions of fitness, and the distinction between multi-level selection 1 (MLS1) and multi-level selection 2 (MLS2).  For MLS1, what Okasha calls the ‘focal’ level is concerned with the number of offspring, in the next generation, of the particles that constitute a collective or group and for MLS2 the ‘focal’ level is concerned with the number of offspring groups in the succeeding generation.  Another key distinction that Okasha addresses is that between aggregate and emergent properties of collectives.  Okasha then tackles heritability and how the concept differs for MLS1 and MLS2 and includes a discussion of how the Price equation can be applied for the two types of multi-level selection.

Chapter three focuses on notions of causality and deals with the fairly subtle notion of cross-level by-products in which apparent selection on one level can in fact result from selection at another level.  In this portion of the book, the author introduces contextual analysis, which relies on linear regression models, and compares it to the approach associated with the Price equation.

What the author describes as philosophical issues take up the fourth chapter.  The section sub-headings will give a sense of the subject matter being addressed: emergence and additivity, screening off and the levels of selection, realism versus pluralism about the levels of selection, and reductionism.

Chapter five is entitled “The Gene’s-Eye View and its Discontents.”  After tracing the gene-centered perspective back to R. A. Fisher and reviewing the contributions of individuals such as W. D. Hamilton, G. C. Williams, and Richard Dawkins, Okasha makes the critical distinction between a gene’s-eye view of evolution and genic selection.  In this context, Okasha notes what he believes to be a shift in position by Dawkins.  Next the author discusses outlaw genes or selfish genetic elements (SGEs).  These DNA sequences manage to be transmitted at increased frequencies into the gametes (the phenomenon of meiotic drive or segregation distortion) and, therefore, into the next generation thereby exhibiting increased fitnesses relative to non-SGEs.  Thus, I would suggest that selfishness is a quantitative not a qualitative trait.  The Price equation and contextual analysis are then compared as to how these two approaches account for the behavior of SGEs.  Okasha then demonstrates why the gene-centered perspective is not, as sometimes claimed, a completely general way to account for any evolutionary scenario, e.g., when dealing with non-genetic inheritance, plants that produce vegetative entities that are often genetically chimeric (i.e., ramets), and insect colonies founded by multiple queens or multiply-mated queens.  The genic perspective also is less obviously successful when non-additive interactions between genes are present, which is reasonably common.  An interesting point that Okasha makes is that whenever SGEs arise, there is likely to be selection on the unlinked ‘law abiding’ genetic elements to suppress the ‘cheaters’ since SGEs typically enhance their own fitnesses at the cost of diminishing the fitness of the organism with respect to which they may reasonably regarded as parasites of a sort.

The sixth chapter addresses the still active and evolving controversy or group selection as of 2006.  Okasha provides historical background, discusses the distinction between MLS1 and MLS2 in the context of the controversy, explores how ideas about kin selection, reciprocal altruism, and evolutionary game theory feature in the debates, and describes the roles of a number of other concepts in the key disagreements in the literature.

The final two chapters address macroevolutionary issues that may be less obviously relevant to those focused on the relevance of evolution to medicine.  Therefore, I will refrain from a detailed description of the content of these sections and just note an insight offered therein. Whenever there is a major evolutionary transition, as from individual genes to whole genomes or single-celled to multi-celled organisms, there must be selection against within-group conflict and selfishness of the ‘lower-level’ units and this selection must be effective for the more-complex level of the biological hierarchy to be successfully established.  Thus, one consequence of relentless competition is cooperation and all genes are not, as Dawkins suggested early in The Selfish Gene (1976, 1989), ruthlessly selfish unless ruthless selfishness embodies some measure of cooperativeness.

References

Hodges, A. Alan Turing: The Enigma. A Touchstone Book, Simon & Schuster, Inc., New York, 1983.

Okasha, Samir. Evolution and the Levels of Selection. Oxford University press, 2006.

Dawkins, R. The Selfish Gene. Oxford University Press, Oxford, 1976, 1989 p. 2.

Tags: additive characters, Alan Turing, causal decomposition, cells, computer science, contextual analysis, cooperation, cross-level by-products, diachronic, emergent characters, evolution, evolutionary game theory, focal level, G. C. Williams, gametes, genes, gene’s-eye perspective, genic selection, George Price, hierarchical organization, kin selection, levels-of-selection controversy, logic, macroevolution, mathematics, maximum deduction, meiotic drive, military code, multi-cellular organisms, multi-level selection 1, multi-level selection 2, pluralism, Price equation, R. A. Fisher, realism, reciprocal altruism, reductionism, Richard Dawkins, Richard Lewontin, selfish genetic element, statistical decomposition, synchronic, W. D. Hamilton


View the original article here

Levels of Selection, Logical Schemes, Selfish Genes, and Misleading Memes

AppId is over the quota
AppId is over the quota

Both Nature and Science are currently celebrating the 100th anniversary of the birth of an icon of logic, computer science, and mathematical biology: Alan Turing.  In reading Andrew Hodges’s spectacular biography of Turing (1983) many years ago I came to appreciate that the subject of the book was both a deeply creative and extraordinarily rigorous thinker.  Although Turing is known for seminal achievements in mathematical logic and computer science, his most directly practical and immediately consequential contribution was his facilitation of the Allied cause in World War II through his guidance of the effort to break the Nazi military code.  This effort called primarily on his prodigious talents for far-reaching inference and it was in reading about this effort that I was prompted to consider a concept that might be called “maximum deduction.”  Turing and his able colleagues needed to make every possible deductive inference (or at least very close to every possible inference) supported by the available data on German military communications in order to solve a problem of immense and immediate impact (the saving of Allied ships from devastating German submarine attacks).

In reading Samir Okasha’s thorough and insightful guide to the theoretical debates about multi-level selection, Evolution and the Levels of Selection (2006), I am reminded of Turing’s logical rigor. Like Turing, Okasha possesses the ability to fully explore the implications of an intellectual position.  Of similar value, he makes key distinctions that elude or at least receive inadequate attention from others and fairly assesses alternative conceptual schemes or theoretical approaches.  For example, his examination of the relative merits of the Price equation versus what he refers to as the “contextual analysis” for assessing and partitioning selection in differing evolutionary scenarios reveals that each has important advantages as well as significant weaknesses.  Much to his credit, he does not seek a neat but oversimplified and misleading conclusion.  The figures are simple but effective and substantially aid the exposition.

I cannot attempt to summarize all of the arguments in the book of about 240 pages because Okasha’s arguments are of sufficient intricacy and subtlety that it would be nearly impossible to substantially compress them without causing serious distortions in the reasoning.  Therefore, I will just note the topics addressed and remark on a limited number of particularly interesting points.

Okasha begins the book by introducing and characterizing the levels-of-selection problem and explicating the essence of natural selection in abstract formal terms.  He then addresses the distinction between the synchronic and diachronic perspectives, where the former deals with the hierarchical organization of the living world (e.g. cells, multicellular organisms, communities of multicellular organisms) such as it is and the latter is concerned with how the hierarchy arose.  Next, the author introduces and explains the interpretation of the equation formulated by George Price forty years ago to describe in mathematical terms the evolution of a population from one generation to the next.  He also delves into the sometimes-consequential differences between statistical and causal decompositions of changes in organismal characters across generation.  This chapter ends with an interesting discussion of the connections between the Price equation and the formal conditions for evolution promulgated more than forty years ago by the eminent population geneticist, Richard Lewontin, which were initially described at the beginning of the chapter.

The second chapter explains the fundamentals of multi-level selection, including explorations of life cycles, relevant definitions of fitness, and the distinction between multi-level selection 1 (MLS1) and multi-level selection 2 (MLS2).  For MLS1, what Okasha calls the ‘focal’ level is concerned with the number of offspring, in the next generation, of the particles that constitute a collective or group and for MLS2 the ‘focal’ level is concerned with the number of offspring groups in the succeeding generation.  Another key distinction that Okasha addresses is that between aggregate and emergent properties of collectives.  Okasha then tackles heritability and how the concept differs for MLS1 and MLS2 and includes a discussion of how the Price equation can be applied for the two types of multi-level selection.

Chapter three focuses on notions of causality and deals with the fairly subtle notion of cross-level by-products in which apparent selection on one level can in fact result from selection at another level.  In this portion of the book, the author introduces contextual analysis, which relies on linear regression models, and compares it to the approach associated with the Price equation.

What the author describes as philosophical issues take up the fourth chapter.  The section sub-headings will give a sense of the subject matter being addressed: emergence and additivity, screening off and the levels of selection, realism versus pluralism about the levels of selection, and reductionism.

Chapter five is entitled “The Gene’s-Eye View and its Discontents.”  After tracing the gene-centered perspective back to R. A. Fisher and reviewing the contributions of individuals such as W. D. Hamilton, G. C. Williams, and Richard Dawkins, Okasha makes the critical distinction between a gene’s-eye view of evolution and genic selection.  In this context, Okasha notes what he believes to be a shift in position by Dawkins.  Next the author discusses outlaw genes or selfish genetic elements (SGEs).  These DNA sequences manage to be transmitted at increased frequencies into the gametes (the phenomenon of meiotic drive or segregation distortion) and, therefore, into the next generation thereby exhibiting increased fitnesses relative to non-SGEs.  Thus, I would suggest that selfishness is a quantitative not a qualitative trait.  The Price equation and contextual analysis are then compared as to how these two approaches account for the behavior of SGEs.  Okasha then demonstrates why the gene-centered perspective is not, as sometimes claimed, a completely general way to account for any evolutionary scenario, e.g., when dealing with non-genetic inheritance, plants that produce vegetative entities that are often genetically chimeric (i.e., ramets), and insect colonies founded by multiple queens or multiply-mated queens.  The genic perspective also is less obviously successful when non-additive interactions between genes are present, which is reasonably common.  An interesting point that Okasha makes is that whenever SGEs arise, there is likely to be selection on the unlinked ‘law abiding’ genetic elements to suppress the ‘cheaters’ since SGEs typically enhance their own fitnesses at the cost of diminishing the fitness of the organism with respect to which they may reasonably regarded as parasites of a sort.

The sixth chapter addresses the still active and evolving controversy or group selection as of 2006.  Okasha provides historical background, discusses the distinction between MLS1 and MLS2 in the context of the controversy, explores how ideas about kin selection, reciprocal altruism, and evolutionary game theory feature in the debates, and describes the roles of a number of other concepts in the key disagreements in the literature.

The final two chapters address macroevolutionary issues that may be less obviously relevant to those focused on the relevance of evolution to medicine.  Therefore, I will refrain from a detailed description of the content of these sections and just note an insight offered therein. Whenever there is a major evolutionary transition, as from individual genes to whole genomes or single-celled to multi-celled organisms, there must be selection against within-group conflict and selfishness of the ‘lower-level’ units and this selection must be effective for the more-complex level of the biological hierarchy to be successfully established.  Thus, one consequence of relentless competition is cooperation and all genes are not, as Dawkins suggested early in The Selfish Gene (1976, 1989), ruthlessly selfish unless ruthless selfishness embodies some measure of cooperativeness.

References

Hodges, A. Alan Turing: The Enigma. A Touchstone Book, Simon & Schuster, Inc., New York, 1983.

Okasha, Samir. Evolution and the Levels of Selection. Oxford University press, 2006.

Dawkins, R. The Selfish Gene. Oxford University Press, Oxford, 1976, 1989 p. 2.

Tags: additive characters, Alan Turing, causal decomposition, cells, computer science, contextual analysis, cooperation, cross-level by-products, diachronic, emergent characters, evolution, evolutionary game theory, focal level, G. C. Williams, gametes, genes, gene’s-eye perspective, genic selection, George Price, hierarchical organization, kin selection, levels-of-selection controversy, logic, macroevolution, mathematics, maximum deduction, meiotic drive, military code, multi-cellular organisms, multi-level selection 1, multi-level selection 2, pluralism, Price equation, R. A. Fisher, realism, reciprocal altruism, reductionism, Richard Dawkins, Richard Lewontin, selfish genetic element, statistical decomposition, synchronic, W. D. Hamilton


View the original article here

Levels of Selection, Logical Schemes, Selfish Genes, and Misleading Memes

AppId is over the quota
AppId is over the quota

Both Nature and Science are currently celebrating the 100th anniversary of the birth of an icon of logic, computer science, and mathematical biology: Alan Turing.  In reading Andrew Hodges’s spectacular biography of Turing (1983) many years ago I came to appreciate that the subject of the book was both a deeply creative and extraordinarily rigorous thinker.  Although Turing is known for seminal achievements in mathematical logic and computer science, his most directly practical and immediately consequential contribution was his facilitation of the Allied cause in World War II through his guidance of the effort to break the Nazi military code.  This effort called primarily on his prodigious talents for far-reaching inference and it was in reading about this effort that I was prompted to consider a concept that might be called “maximum deduction.”  Turing and his able colleagues needed to make every possible deductive inference (or at least very close to every possible inference) supported by the available data on German military communications in order to solve a problem of immense and immediate impact (the saving of Allied ships from devastating German submarine attacks).

In reading Samir Okasha’s thorough and insightful guide to the theoretical debates about multi-level selection, Evolution and the Levels of Selection (2006), I am reminded of Turing’s logical rigor. Like Turing, Okasha possesses the ability to fully explore the implications of an intellectual position.  Of similar value, he makes key distinctions that elude or at least receive inadequate attention from others and fairly assesses alternative conceptual schemes or theoretical approaches.  For example, his examination of the relative merits of the Price equation versus what he refers to as the “contextual analysis” for assessing and partitioning selection in differing evolutionary scenarios reveals that each has important advantages as well as significant weaknesses.  Much to his credit, he does not seek a neat but oversimplified and misleading conclusion.  The figures are simple but effective and substantially aid the exposition.

I cannot attempt to summarize all of the arguments in the book of about 240 pages because Okasha’s arguments are of sufficient intricacy and subtlety that it would be nearly impossible to substantially compress them without causing serious distortions in the reasoning.  Therefore, I will just note the topics addressed and remark on a limited number of particularly interesting points.

Okasha begins the book by introducing and characterizing the levels-of-selection problem and explicating the essence of natural selection in abstract formal terms.  He then addresses the distinction between the synchronic and diachronic perspectives, where the former deals with the hierarchical organization of the living world (e.g. cells, multicellular organisms, communities of multicellular organisms) such as it is and the latter is concerned with how the hierarchy arose.  Next, the author introduces and explains the interpretation of the equation formulated by George Price forty years ago to describe in mathematical terms the evolution of a population from one generation to the next.  He also delves into the sometimes-consequential differences between statistical and causal decompositions of changes in organismal characters across generation.  This chapter ends with an interesting discussion of the connections between the Price equation and the formal conditions for evolution promulgated more than forty years ago by the eminent population geneticist, Richard Lewontin, which were initially described at the beginning of the chapter.

The second chapter explains the fundamentals of multi-level selection, including explorations of life cycles, relevant definitions of fitness, and the distinction between multi-level selection 1 (MLS1) and multi-level selection 2 (MLS2).  For MLS1, what Okasha calls the ‘focal’ level is concerned with the number of offspring, in the next generation, of the particles that constitute a collective or group and for MLS2 the ‘focal’ level is concerned with the number of offspring groups in the succeeding generation.  Another key distinction that Okasha addresses is that between aggregate and emergent properties of collectives.  Okasha then tackles heritability and how the concept differs for MLS1 and MLS2 and includes a discussion of how the Price equation can be applied for the two types of multi-level selection.

Chapter three focuses on notions of causality and deals with the fairly subtle notion of cross-level by-products in which apparent selection on one level can in fact result from selection at another level.  In this portion of the book, the author introduces contextual analysis, which relies on linear regression models, and compares it to the approach associated with the Price equation.

What the author describes as philosophical issues take up the fourth chapter.  The section sub-headings will give a sense of the subject matter being addressed: emergence and additivity, screening off and the levels of selection, realism versus pluralism about the levels of selection, and reductionism.

Chapter five is entitled “The Gene’s-Eye View and its Discontents.”  After tracing the gene-centered perspective back to R. A. Fisher and reviewing the contributions of individuals such as W. D. Hamilton, G. C. Williams, and Richard Dawkins, Okasha makes the critical distinction between a gene’s-eye view of evolution and genic selection.  In this context, Okasha notes what he believes to be a shift in position by Dawkins.  Next the author discusses outlaw genes or selfish genetic elements (SGEs).  These DNA sequences manage to be transmitted at increased frequencies into the gametes (the phenomenon of meiotic drive or segregation distortion) and, therefore, into the next generation thereby exhibiting increased fitnesses relative to non-SGEs.  Thus, I would suggest that selfishness is a quantitative not a qualitative trait.  The Price equation and contextual analysis are then compared as to how these two approaches account for the behavior of SGEs.  Okasha then demonstrates why the gene-centered perspective is not, as sometimes claimed, a completely general way to account for any evolutionary scenario, e.g., when dealing with non-genetic inheritance, plants that produce vegetative entities that are often genetically chimeric (i.e., ramets), and insect colonies founded by multiple queens or multiply-mated queens.  The genic perspective also is less obviously successful when non-additive interactions between genes are present, which is reasonably common.  An interesting point that Okasha makes is that whenever SGEs arise, there is likely to be selection on the unlinked ‘law abiding’ genetic elements to suppress the ‘cheaters’ since SGEs typically enhance their own fitnesses at the cost of diminishing the fitness of the organism with respect to which they may reasonably regarded as parasites of a sort.

The sixth chapter addresses the still active and evolving controversy or group selection as of 2006.  Okasha provides historical background, discusses the distinction between MLS1 and MLS2 in the context of the controversy, explores how ideas about kin selection, reciprocal altruism, and evolutionary game theory feature in the debates, and describes the roles of a number of other concepts in the key disagreements in the literature.

The final two chapters address macroevolutionary issues that may be less obviously relevant to those focused on the relevance of evolution to medicine.  Therefore, I will refrain from a detailed description of the content of these sections and just note an insight offered therein. Whenever there is a major evolutionary transition, as from individual genes to whole genomes or single-celled to multi-celled organisms, there must be selection against within-group conflict and selfishness of the ‘lower-level’ units and this selection must be effective for the more-complex level of the biological hierarchy to be successfully established.  Thus, one consequence of relentless competition is cooperation and all genes are not, as Dawkins suggested early in The Selfish Gene (1976, 1989), ruthlessly selfish unless ruthless selfishness embodies some measure of cooperativeness.

References

Hodges, A. Alan Turing: The Enigma. A Touchstone Book, Simon & Schuster, Inc., New York, 1983.

Okasha, Samir. Evolution and the Levels of Selection. Oxford University press, 2006.

Dawkins, R. The Selfish Gene. Oxford University Press, Oxford, 1976, 1989 p. 2.

Tags: additive characters, Alan Turing, causal decomposition, cells, computer science, contextual analysis, cooperation, cross-level by-products, diachronic, emergent characters, evolution, evolutionary game theory, focal level, G. C. Williams, gametes, genes, gene’s-eye perspective, genic selection, George Price, hierarchical organization, kin selection, levels-of-selection controversy, logic, macroevolution, mathematics, maximum deduction, meiotic drive, military code, multi-cellular organisms, multi-level selection 1, multi-level selection 2, pluralism, Price equation, R. A. Fisher, realism, reciprocal altruism, reductionism, Richard Dawkins, Richard Lewontin, selfish genetic element, statistical decomposition, synchronic, W. D. Hamilton


View the original article here

Everyday Health Editors' Product Review Blog

Reuters: Business Travel

MedicineNet Nutrition, Food and Recipes General

Pages

MedicineNet Diet and Weight Management General

Frommer's Deals and News

Behind the Guides

Media Releases: News Desk

About.com Day Trading

Frommers.com Cruise Blog

Arthur Frommer Online

Dictionary.com Word of the Day

The Full Feed from HuffingtonPost.com